Gensight Biologics SA (SIGHT) — Working Capital to Net Assets Ratio
Gensight Biologics SA (SIGHT) has a Working Capital to Net Assets ratio of 30.8% as of December 2025. Working capital of €-7.69 Million (current assets of €4.98 Million minus current liabilities of €12.67 Million) is measured against net assets of €-24.94 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See SIGHT free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Gensight Biologics SA Working Capital to Net Assets (2012–2025)
This chart shows how Gensight Biologics SA's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the ratio stands at 30.8%, reflecting working capital of €-7.69 Million against net assets of €-24.94 Million EUR. See Gensight Biologics SA (SIGHT) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Gensight Biologics SA (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Gensight Biologics SA from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Gensight Biologics SA.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 30.8% | €-7.69 Million | €-24.94 Million | €4.98 Million | €12.67 Million | ▼ -33.4 pp |
| 2024 | 64.2% | €-17.27 Million | €-26.92 Million | €5.34 Million | €22.62 Million | ▲ +3.1 pp |
| 2023 | 61.1% | €-18.76 Million | €-30.70 Million | €6.53 Million | €25.29 Million | ▲ +115.5 pp |
| 2022 | -54.4% | €8.30 Million | €-15.28 Million | €22.95 Million | €14.64 Million | ▼ -249.0 pp |
| 2021 | 194.6% | €31.12 Million | €15.99 Million | €53.36 Million | €22.24 Million | ▼ -33.7 pp |
| 2020 | 228.3% | €26.64 Million | €11.67 Million | €43.76 Million | €17.12 Million | ▲ +81.4 pp |
| 2019 | 146.9% | €17.26 Million | €11.75 Million | €27.77 Million | €10.51 Million | ▲ +40.2 pp |
| 2018 | 106.8% | €25.48 Million | €23.87 Million | €35.08 Million | €9.60 Million | ▲ +3.6 pp |
| 2017 | 103.1% | €56.72 Million | €55.00 Million | €60.81 Million | €4.09 Million | ▼ -0.3 pp |
| 2016 | 103.4% | €55.17 Million | €53.34 Million | €58.07 Million | €2.89 Million | ▲ +5.2 pp |
| 2015 | 98.3% | €28.82 Million | €29.33 Million | €35.11 Million | €6.29 Million | ▼ -2.9 pp |
| 2014 | 101.2% | €10.70 Million | €10.58 Million | €14.27 Million | €3.56 Million | ▲ +4.7 pp |
| 2013 | 96.4% | €16.36 Million | €16.97 Million | €18.26 Million | €1.90 Million | ▼ -13.9 pp |
| 2012 | 110.4% | €-73.35K | €-66.47K | €53.73K | €127.08K | — |